while on the second's already existing laboratory with 100 employees to develop the next-generation sequencing technologies. In May 2018, reached an agreement with Mount Sinai Hospital (Toronto), Canada, for first installation of BGISEQ platforms in North America.

BGI Genomics, a subsidiary of the group made an initial public offering in July 2017 at Shenzhen Stock Exchange.